Intrathecal injection of a single dose of Ziconotide (Prialt) to evaluate the option of continuous administration via implanted pump. A Pilot Study.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2013
At a glance
- Drugs Ziconotide (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- 28 Mar 2012 Actual initiation date (21 Oct 2009) added as reported by European Clinical Trials Database.
- 18 Nov 2011 United Kingdom Clinical Research Network reports accrual to date changed from 90% to 100%.
- 18 Nov 2011 Planned End Date changed from 31 May 2011 to 14 Jun 2011 as reported by United Kingdom Clinical Research Network record.